Pharmacology

Opioid-induced respiratory depression

Risk factors for opioid-induced respiratory depression include impaired rental clearance, high opioid tolerance, and sleep apnea history. Tools for assessing patient sedation levels include…
anesthesia

An overview of neuraxial anesthesia

Understand the basics so you can effectively manage your patients. Takeaways: Neuraxial anesthesia is the administration of medication into the subarachnoid or epidural space…
cannabis

Cannabinoid hyperemesis syndrome explained

Cannabinoid hyperemesis syndrome is a three-phase cyclical syndrome characterized by periods of intense nausea and vomiting, frequently relieved with hot water bathing, that poses…

New treatment for multiple myeloma

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of  adult patients with multiple myeloma. Isatuximab-irfc was previously…

The changing face of cystic fibrosis

It’s no longer a childhood illness. The Cystic Fibrosis Foundation Patient Data Registry shows that more than 54% of people with cystic fibrosis live…

Promoting safe use of parenteral anticoagulants

Parenteral anticoagulants—unfractionated and low-molecular-weight heparin—primarily are used to prevent and treat VTE (deep vein thrombosis [DVT] and pulmonary embolism [PE]) associated with medical conditions…

Opioid-induced respiratory depression

Risk factors for opioid-induced respiratory depression include impaired rental clearance, high opioid tolerance, and sleep apnea history. Tools for assessing patient sedation…
anesthesia

An overview of neuraxial anesthesia

Understand the basics so you can effectively manage your patients. Takeaways: Neuraxial anesthesia is the administration of medication into the subarachnoid or…
cannabis

Cannabinoid hyperemesis syndrome explained

Cannabinoid hyperemesis syndrome is a three-phase cyclical syndrome characterized by periods of intense nausea and vomiting, frequently relieved with hot water bathing,…

New treatment for multiple myeloma

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of  adult patients with multiple myeloma. Isatuximab-irfc…

Promoting safe use of parenteral anticoagulants

Parenteral anticoagulants—unfractionated and low-molecular-weight heparin—primarily are used to prevent and treat VTE (deep vein thrombosis [DVT] and pulmonary embolism [PE]) associated with…

Test Your Knowledge

Emotional Intel TYK

In what way does emotional intelligence affect nursing leaders in team and patient care settings?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.